Yahoo Finance

• Q4 Revenue: $111 million, a decline of 3% from the prior year.

• Full Year Revenue: $440 million, down 10% from the prior year.

• Industrial Solutions Q4 Revenue: $71 million, an increase of 11%.

• Healthcare Solutions Q4 Revenue: $40 million, a decrease of 21%.

• Non-GAAP Gross Margin Q4: 31.3%, down from 39.8% in the prior year period.

• Non-GAAP Gross Margin Full Year: 37.4%, compared to 40.6% in the prior year.

• Non-GAAP Operating Expense Q4: $58.4 million, showing sequential and year-over-year improvements.

• Adjusted EBITDA Q4: Negative $19.1 million, a decline of $5 million from the prior year.

• Adjusted EBITDA Full Year: Negative $66.4 million, a decline of $40 million from the prior year.

• Cash and Cash Equivalents: $171 million at year-end.

• Debt Repurchase: $87 million used to repurchase $111 million of debt in March.

• 2025 Revenue Guidance: $420 million to $435 million.

• 2025 Non-GAAP Gross Profit Margin Guidance: 37% to 39%.

• 2025 Non-GAAP Operating Expense Guidance: $200 million to $220 million.

• Warning! GuruFocus has detected 6 Warning Signs with DDD.

Release Date: March 27, 2025

For the complete transcript of the earnings call, please refer to the full earnings call transcript.

Positive Points

• 3D Systems Corp (NYSE:DDD) reported stabilization and strengthening in customer demand for new capacity in Q4 2024, particularly in industrial printers.

• The company's orthodontics business grew over 30% in 2024, contributing positively to material sales.

• 3D Systems Corp (NYSE:DDD) has a strong position in the dental market, with a significant opportunity estimated at over $1 billion in the US alone.

• The company announced cost reduction and restructuring actions targeting over $50 million in annualized savings, expected to improve profitability.

• 3D Systems Corp (NYSE:DDD) has a strong balance sheet with over $170 million in cash and cash equivalents, and expects to be in a net cash positive position following the divestiture of its Geomagic software platform.

Negative Points

• 3D Systems Corp (NYSE:DDD) experienced a $9 million reduction in revenue and gross margin in Q4 2024 due to a change in accounting estimates related to its Regenerative Medicine program.

• The company's Healthcare Solutions segment saw a 21% decline in Q4 2024 revenues, impacted by the accounting change and softness in printer sales.

• Full year 2024 revenues declined 10% from the prior year, primarily due to broader macroeconomic pressures on printer sales.

• Non-GAAP gross margin for Q4 2024 decreased to 31.3% from 39.8% in the prior year, largely due to the change in accounting estimates.

• 3D Systems Corp (NYSE:DDD) reported a negative adjusted EBITDA of $66.4 million for the full year 2024, a decline of $40 million from the prior year.